Immunotherapy: Programming Your Immune System to Target Cancer Cells

MUSC Health medical oncologist John M. Wrangle, M.D., and cancer immunologist Mark P. Rubinstein, Ph.D., discuss the promise of immunotherapy and their close collaboration that has led to a clinical trial of a novel combination immunotherapy for non-small cell lung cancer.

More at Progressnotes, MUSC’s Medical Magazine



November 16, 2016

Created by

The Medical University of South Carolina

Mark P. Rubinstein, Ph.D.

Mark P. Rubinstein, Ph.D.

Assistant Professor of Surgery

View full profile